#dcvax $nwbo #gbm

Great card in her hand as $nwbo Linda Powers negotiates potential partnerships along with the combo trial results.....🤔

#dcvax $nwbo #gbm

T Cell Features in Glioblastoma May Guide Therapeutic Strategies to Overcome Microenvironment Immunosuppression
by Agnese Losurdo et al

Another Doctor (Lead author) who fails to mention that her medical interests are Early phase clinical studies (Phase 1

#dcvax $nwbo #gbm

'The company has struggled to find success combining it with other medications'

Not exactly true... just all of the parties concerned have their lips well and truly sealed....for now! 🤫🤫🤫

$NWBO #DCVax Thanks for the cheap shares you piece of shit! #CitadelScandal

Ask yourself - why would she continue to get awards for it if dcvax failed.

Do not listen to the noise and fud
produced by the MM paid shills.

$nwbo #nwbo

Really…

NWBO DCVax-L. I was Administered the DCVax
In 2015, 9 years later I’m still FU$KING here. No tumor recurrence. I expect this from paid $HILL’S put when the disinformation comes from a Doctor it hits different. Shame on you Dr. Losurdo.

#dcvax $nwbo #gbm

Product approval announcements:

'We have continued work to publish announcements to coincide with the conclusion of regulatory assessments, delivering on a key objective as listed within our corporate plan to build public trust and understanding of our work.

#dcvax $nwbo #gbm

Some interesting remarks on the development of Cancer Vaccines...

Can you tell us a bit about your career and what you are working on right now?
SJ: The company that I head, Calviri, is focused on a project I initiated around 20 years ago where the goal is

#dcvax $nwbo #gbm

New Brain Tumor Clinical Trials: January- March 2024

'It can be hard to keep track of new clinical trial opportunities opening across the United States. There are many clinical trials actively enrolling patients. This report provides a summary of the studies

Thinking back to 2018, I believe the Journal of Translational Medicine held back publication of the #DCVax interim results to coincide with ASCO. Nature will do the same. JTM and media push was on May 18. I believe we see the combo results in Nature the week of the 20th. $NWBO

#dcvax $nwbo #gbm

Sounds good to me....

#dcvax $nwbo #gbm

Even better news, the link gives the US Patent as showing 'Pending' however, the same patent on the site (WIPO - World Intellectual Property Organization) shows correspondence for 'Intention to Grant' in the text for a total of 38 Contracting states which was

$nwbo #dcvax #glioblastoma #gbm

I hope some people with firsthand experience with DCVax-L can let Sophie Kinsella know this #CancerVaccine is #Safe , #Effective & #NonToxic . Waiting for approval in the UK, but can be had NOW via the UK Specials Program.

brainstrust.org.uk/wp-content/upl…

#dcvax $nwbo #gbm

New FDA trial innovation center launches with demonstration to increase industry interactions

endpts.com/new-fda-trial-…

Have MHRA approve $nwbo ($dcvax)as the MAA was submitted December 2023 and having NICE reimburse for the treatment. Help fund and expedite additional combo trials.

#dcvax $nwbo #gbm

Interesting observations from the authors of this article on IL-7 (Revimmune)

'Harnessing the Power of IL-7 to Boost T Cell Immunity in Experimental and Clinical Immunotherapies'
Published online Feb 15, 2024.

'Using IL-7 as a standalone therapy is limited

#dcvax $nwbo #gbm

Bodes well for #nwbo 's Pediatric trials applications in nGBM and rGBM forming pre-requisite of MHRA approval.

MHRA performance date for assessment of clinical trials and established medicines

The latest MHRA performance data shows that clinical trials

#dcvax $nwbo #gbm

Just the start of many awards being presented to the brilliant Linda Liau....

The Society of Neurological Surgeons HOSTED BY: 115TH ANNUAL MEETING — MAY 18-20, 2024 —

Winn Prize Lecture - Linda M. Liau, MD, PhD, MBA

H. Richard Winn, MD Prize

In 2007, the

#dcvax $nwbo #gbm

'Therefore, these findings instill a sense of hope within the medical community and patients alike'

#dcvax $nwbo #gbm

EMA publishes new guidance on real-world evidence generation service
22 APR 2024

The European Medicines Agency (EMA) has released new guidance detailing the types of studies that can be performed for RWE generation and how they can support RWD studies in the